EAGLE GLOBAL ADVISORS LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAGLE GLOBAL ADVISORS LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$2,865,000
-2.0%
156,897
-2.3%
0.21%
-7.8%
Q4 2020$2,923,000
-4.3%
160,586
-6.2%
0.23%
-16.4%
Q3 2020$3,054,000
-1.4%
171,202
-0.9%
0.28%
-1.8%
Q2 2020$3,097,000
+13.7%
172,715
-3.8%
0.28%
+1.4%
Q1 2020$2,724,000
-26.4%
179,464
-4.3%
0.28%
+47.6%
Q4 2019$3,701,000
+75.7%
187,565
+53.2%
0.19%
+107.8%
Q3 2019$2,106,000
-12.9%
122,440
-10.3%
0.09%
-7.2%
Q2 2019$2,417,000
+13.4%
136,544
+30.4%
0.10%
+16.9%
Q1 2019$2,132,000104,6720.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Glenview Capital Management 16,104,222$294,063,0004.98%
GMT CAPITAL CORP 2,468,695$45,078,0003.31%
MANAGED ASSET PORTFOLIOS, LLC 1,065,756$19,461,0003.13%
Blackcrane Capital, LLC 14,571$1,723,0002.72%
BFAM Partners (Cayman) Ltd 328,690$6,002,0002.36%
Paulson & Co. 4,727,415$86,323,0001.98%
Mondrian Investment Partners LTD 3,510,404$59,677,0001.28%
Lumbard & Kellner, LLC 135,550$2,264,0000.80%
DAVIDSON INVESTMENT ADVISORS 500,203$9,134,0000.78%
TFG Asset Management GP Ltd 589,390$10,762,0000.77%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders